Yuxiang Lin - Search Results

Year	Number of Results
2010	2
2011	3
2012	1
2013	2
2014	3
2015	1
2016	2
2017	5
2018	6
2019	5
2020	13
2021	16
2022	19
2023	16
2024	10

1

CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1.

Lin Y, Zhang J, Li Y, Guo W, Chen L, Chen M, Chen X, Zhang W, Jin X, Jiang M, Xiao H, Wang C, Song C, Fu F. Lin Y, et al. J Transl Med. 2022 Jan 6;20(1):17. doi: 10.1186/s12967-021-03206-5. J Transl Med. 2022. PMID: 34991621 Free PMC article.

2

Tumor pH and its measurement.

Zhang X, Lin Y, Gillies RJ. Zhang X, et al. Among authors: lin y. J Nucl Med. 2010 Aug;51(8):1167-70. doi: 10.2967/jnumed.109.068981. Epub 2010 Jul 21. J Nucl Med. 2010. PMID: 20660380 Free PMC article. Review.

3

Prioritizing prognostic-associated subpopulations and individualized recurrence risk signatures from single-cell transcriptomes of colorectal cancer.

Tong M, Lin Y, Yang W, Song J, Zhang Z, Xie J, Tian J, Luo S, Liang C, Huang J, Yu R. Tong M, et al. Among authors: lin y. Brief Bioinform. 2023 May 19;24(3):bbad078. doi: 10.1093/bib/bbad078. Brief Bioinform. 2023. PMID: 36946415

4

Comprehensive proteome, phosphoproteome and kinome characterization of luminal A breast cancer.

Yang G, Zuo C, Lin Y, Zhou X, Wen P, Zhang C, Xiao H, Jiang M, Fujita M, Gao XD, Fu F. Yang G, et al. Among authors: lin y. Front Oncol. 2023 Mar 31;13:1127446. doi: 10.3389/fonc.2023.1127446. eCollection 2023. Front Oncol. 2023. PMID: 37064116 Free PMC article.

5

MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma.

Lin YX, Pan JY, Feng WD, Huang TC, Li CZ. Lin YX, et al. Eur J Med Res. 2023 Dec 14;28(1):589. doi: 10.1186/s40001-023-01571-z. Eur J Med Res. 2023. PMID: 38093387 Free PMC article.

6

SlTPL1 Silencing Induces Facultative Parthenocarpy in Tomato.

He M, Song S, Zhu X, Lin Y, Pan Z, Chen L, Chen D, Hu G, Huang B, Chen M, Wu C, Chen R, Bouzayen M, Zouine M, Hao Y. He M, et al. Among authors: lin y. Front Plant Sci. 2021 May 20;12:672232. doi: 10.3389/fpls.2021.672232. eCollection 2021. Front Plant Sci. 2021. PMID: 34093628 Free PMC article.

7

Tyrosine kinase inhibitors in HER2-positive breast cancer brain metastases: A systematic review and meta-analysis.

Yu Y, Huang K, Lin Y, Zhang J, Song C. Yu Y, et al. Among authors: lin y. Cancer Med. 2023 Jul;12(14):15090-15100. doi: 10.1002/cam4.6180. Epub 2023 May 31. Cancer Med. 2023. PMID: 37255389 Free PMC article.

8

Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis.

He P, Li J, Chen M, Huang M, Qiu Y, Cai Q, Lin Y, Wang C, Fu F. He P, et al. Among authors: lin y. Breast Cancer Res Treat. 2024 Jan;203(1):13-28. doi: 10.1007/s10549-023-07105-9. Epub 2023 Oct 3. Breast Cancer Res Treat. 2024. PMID: 37787817 Review.

9

Application of individualized differential expression analysis in human cancer proteome.

Liu Y, Lin Y, Yang W, Lin Y, Wu Y, Zhang Z, Lin N, Wang X, Tong M, Yu R. Liu Y, et al. Among authors: lin y. Brief Bioinform. 2022 May 13;23(3):bbac096. doi: 10.1093/bib/bbac096. Brief Bioinform. 2022. PMID: 35368072

10

Integrative proteomic and phosphoproteomic profiling of invasive micropapillary breast carcinoma.

Chen X, Lin Y, Jin X, Zhang W, Guo W, Chen L, Chen M, Li Y, Fu F, Wang C. Chen X, et al. Among authors: lin y. J Proteomics. 2022 Apr 15;257:104511. doi: 10.1016/j.jprot.2022.104511. Epub 2022 Feb 6. J Proteomics. 2022. PMID: 35139397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year